| Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project |
19 |
| ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 2-reagent selection and assay optimization for high-sensitivity testing |
12 |
| CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping |
11 |
| ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 3-data analysis, reporting and case studies |
11 |
| AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia |
10 |
| Flow Cytometry Applications in the Diagnosis of T/NK-Cell Lymphoproliferative Disorders |
9 |
| Bright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit Lymphomas with a Moderate Sensitivity and High SpecificityKey terms |
9 |
| Extended immunophenotyping reference values in a healthy pediatric population |
9 |
| A standardized flow cytometry procedure for the monitoring of regulatory T cells in clinical trials |
8 |
| A New Method for Evaluating Stallion Sperm Viability and Mitochondrial Membrane Potential in Fixed Semen Samples |
8 |
| Platelet characteristics in patients with essential thrombocytosis |
8 |
| Evaluation of New Markers for Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia: CD73 and CD86 Are the Most Relevant New Markers to Increase the Efficacy of MRD Assay |
8 |
| CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia |
8 |
| Human innate lymphoid cells (ILCs): Toward a uniform immune-phenotyping |
7 |
| Quantitative Flow Cytometry: Concerns and Recommendations in Clinic and Research |
7 |
| Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? |
7 |
| ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 4-assay validation and quality assurance |
6 |
| The current role of clinical flow cytometry in the evaluation of mature B-cell neoplasms |
6 |
| A novel flow cytometric assay for detection of residual disease in patients with B-lymphoblastic leukemia/lymphoma post anti-CD19 therapy |
6 |
| The utility of flow cytometry in differentiating NK/T cell lymphoma from indolent and reactive NK cell proliferations |
6 |
| Visualization of Cell Composition and Maturation in the Bone Marrow Using 10-Color Flow Cytometry and Radar Plots |
6 |
| A Novel Automatic Digital Algorithm that Accurately Quantifies Steatosis in NAFLD on Histopathological Whole-Slide ImagesKey terms |
6 |
| Influence of IL- IL- and TNF- on human mast cell activation: Lessons from single cell analysis by flow cytometry |
5 |
| The Fraction of CD117/c-KIT-Expressing Erythroid Precursors Predicts ESA Response in Low-Risk Myelodysplastic Syndromes |
5 |
| Multiparameter Flow Cytometry Applications in the Diagnosis of Mixed Phenotype Acute Leukemia |
5 |
| Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms |
5 |
| A comprehensive assessment of immunophenotyping performed in cryopreserved peripheral whole blood |
5 |
| High-sensitivity 5 6 and 7-color PNH WBC assays for both Canto II and Navios platforms |
5 |
| Flow cytometry vs optical microscopy in the evaluation of the genotoxic potential of xenobiotic compounds |
5 |
| Applications of Flow Cytometric Immunophenotyping in the Diagnosis and Posttreatment Monitoring of B and T Lymphoblastic Leukemia/Lymphoma |
5 |
| Flow Cytometry Assessment of CD26(+) Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia |
5 |
| Differential Expression of CD CD and CD200 in Classic Versus Variant Hairy Cell Leukemia |
5 |
| Monitoring CD49d Receptor Occupancy: A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis Patients |
5 |
| ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 1-clinical utility |
5 |
| Identification of functionally primitive and immunophenotypically distinct subpopulations in secondary acute myeloid leukemia by mass cytometry |
5 |
| PhenoGraph and viSNE facilitate the identification of abnormal T-cell populations in routine clinical flow cytometric data |
4 |
| Normal variation of bone marrow B-cell precursors according to age - reference ranges for studies in myelodysplastic syndromes in Brazil |
4 |
| Labile iron pool as a parameter to monitor iron overload and oxidative stress status in -thalassemic erythrocytes |
4 |
| Common flow cytometry pitfalls in diagnostic hematopathology |
4 |
| Expression of CD43 in chronic lymphoproliferative leukemias |
4 |
| Performance Characteristics of a Non-Fluorescent Aerolysin-Based Paroxysmal Nocturnal Hemoglobinuria (PNH) Assay for Simultaneous Evaluation of PNH Neutrophils and PNH Monocytes by Flow Cytometry, Following Published PNH Guidelines |
4 |
| Functional Impairment of Circulating Fc epsilon RI+ Monocytes and Myeloid Dendritic Cells in Hepatocellular Carcinoma and Cholangiocarcinoma PatientsKey terms |
4 |
| A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced Interpreters |
3 |
| Use of flow cytometry in the phenotypic diagnosis of hodgkin's lymphoma |
3 |
| Detection of Minimal Residual Disease in B Cell Acute Lymphoblastic Leukemia Using an Eight-Color Tube with Dried Antibody ReagentsKey terms |
3 |
| Interlaboratory comparison of the TransFix (R)/EDTA Vacuum Blood Collection tube with the 5 mL Cyto-Chex (R) BCT |
3 |
| Evidence of a role for functional heterogeneity in multidrug resistance transporters in clinical trials of P-glycoprotein modulation in acute myeloid leukemia |
3 |
| High-dimensional single cell mapping of cerium distribution in the lung immune microenvironment of an active smoker |
3 |
| BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma |
3 |
| Minimal residual disease and log-reduction of plasma cells are associated with superior response after double autologous stem cell transplant in younger patients with multiple myeloma |
3 |
